14TH ADRIATIC CONGRESS OF PHARMACOECONOMICS AND OUTCOMES RESEARCH WITH THE FOCUS ON CEE COUNTRIES
Dear Colleagues!
Please be kindly informed that the detailed congress program is now available for download at the following link:
https://pharmacoeconomics-congress.eu/index.php?id=69.
We are looking forward to welcoming you soon to beautiful Brijuni islands and wishing you a safe travel!
With kind regards,
Congress Organizing Comittee
Dear Colleagues,
Please be informed that the 14th Adriatic Congress of Pharmacoeconomics and Outcomes Research with the focus on CEE Countries, will take place at the Conference Centre of Hotel Istra, Brijuni, Croatia, April 23-25, 2026 and will be organized by the Section for Pharmacoeconomics and Outcomes Research of the Croatian Society for Clinical Pharmacology and Therapeutics, Croatian Medical Association.
The main objective of this year congress is to intensify and enhance professional and scientific discussions and collaboration between various stakeholders in support of the following overarching topic:
“UNLOCKING ECONOMIC GROWTH THROUGH VALUE‑DRIVEN INVESTMENT IN HEALTHCARE INNOVATION IN CENTRAL AND EASTERN EUROPE.”
Over the past several years, this Congress has focused on assessing the situation in Central and Eastern Europe (CEE), particularly in relation to patient access to innovation and equity, while identifying gaps compared with more developed EU countries. Building on this foundation, the primary objective of the 2026 Congress is to explore sustainable, value‑driven, and effective approaches to accelerating patient access to healthcare innovation in CEE. Evidence consistently demonstrates that improved access not only enhances health outcomes and life expectancy but also contributes to sustained economic growth.
During the same time, the capacity of CEE countries has strengthened across academia, government institutions, and the health technology industry. Importantly, patient organizations have also evolved into increasingly effective partners within this ecosystem. These developments suggest that the necessary preconditions are now in place to move beyond problem identification and toward the implementation of optimal, collaborative solutions. Achieving this will require active engagement from all relevant stakeholders, working together to define, agree upon, and implement these solutions. The Congress therefore invites contributions that advance scholarly debate and evidence‑based policy dialogue across the following thematic domains:
- Sustainable models for ensuring equitable patient access to, and long‑term financing of, medical innovation in Central and Eastern Europe (CEE)
- Strengthening the role of patients and patient‑reported perspectives in healthcare decision‑making and policy development across CEE countries
- Critical reflections and lessons learned from the implementation of the European Union Health Technology Assessment (EU HTA) Regulation
- Strategic and systemic implications of the new European Pharmaceutical Strategy for national healthcare systems and patient access to innovation
- Health‑economic evaluations and outcomes research in selected therapeutic areas of particular relevance to CEE healthcare priorities
- The integration of patient‑centred outcomes as key performance indicators informing national healthcare strategies, planning, and policy evaluation
Additionally, the full congress agenda will also comprise other important topics as well, such as development of healthcare policies, pharmaceutical pricing and reimbursement, comparative efficacy studies, outcomes research, value of health and health interventions, and many others.
Based on previous experience and recognized regional importance of this congress, we are expecting between 120-160 participants, attending both in person or virtually, from more than 12 countries of Central, South and East Europe, from different fields, personally contributing and working together for the success of this congress and positive impact it has on fostering collaboration at national and regional levels.
If you find this programme aligned with your scientific and professional interests, we would be delighted to welcome you as an active contributor and/or participant at the 14th Adriatic Congress of Pharmacoeconomics and Outcomes Research, with a focus on Central and Eastern European countries.
We very much look forward to welcoming you to the Brijuni Islands, Croatia.
With kind regards,
Congress Organizing Comittee
Tatjana Koprtla mag.cin
Events and Marketing Manager
O-Tours PCO d.o.o.
Gajeva 6 / 1 st floor
HR-10000 Zagreb
Croatia
Telephone : +385- 1- 4831444
Mobile : +385-98-9805716
Email : tatjana.koprtla@otours.hr
Web: www.otours.hr